Incidence and management of "no-reflow" following percutaneous coronary interventions

R. V. Kelly, Mauricio G Cohen, G. A. Stouffer

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

No-reflow is a complex condition associated with inadequate myocardial perfusion of the coronary artery in the absence of epicardial obstruction. It can occur in several settings, including percutaneous coronary intervention, especially in complex thrombotic lesions of native arteries and vein grafts and in primary angioplasty. The causes of no-reflow are not completely understood, and current treatments consist of intracoronary vasodilators, antithrombotic therapies, and mechanical devices (including aspiration thrombectomy catheters and embolic protection devices).

Original languageEnglish
Pages (from-to)78-85
Number of pages8
JournalAmerican Journal of the Medical Sciences
Volume329
Issue number2
DOIs
StatePublished - Feb 1 2005
Externally publishedYes

Fingerprint

Percutaneous Coronary Intervention
Embolic Protection Devices
Thrombectomy
Incidence
Vasodilator Agents
Angioplasty
Veins
Coronary Vessels
Catheters
Arteries
Perfusion
Transplants
Equipment and Supplies
Therapeutics

Keywords

  • Distal embolic protection
  • Myocardial infarction
  • Myocardial perfusion
  • No-reflow
  • Percutaneous coronary intervention

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Incidence and management of "no-reflow" following percutaneous coronary interventions. / Kelly, R. V.; Cohen, Mauricio G; Stouffer, G. A.

In: American Journal of the Medical Sciences, Vol. 329, No. 2, 01.02.2005, p. 78-85.

Research output: Contribution to journalArticle

@article{a237b25ca88a4f118c23efbcb4c1ca7e,
title = "Incidence and management of {"}no-reflow{"} following percutaneous coronary interventions",
abstract = "No-reflow is a complex condition associated with inadequate myocardial perfusion of the coronary artery in the absence of epicardial obstruction. It can occur in several settings, including percutaneous coronary intervention, especially in complex thrombotic lesions of native arteries and vein grafts and in primary angioplasty. The causes of no-reflow are not completely understood, and current treatments consist of intracoronary vasodilators, antithrombotic therapies, and mechanical devices (including aspiration thrombectomy catheters and embolic protection devices).",
keywords = "Distal embolic protection, Myocardial infarction, Myocardial perfusion, No-reflow, Percutaneous coronary intervention",
author = "Kelly, {R. V.} and Cohen, {Mauricio G} and Stouffer, {G. A.}",
year = "2005",
month = "2",
day = "1",
doi = "10.1097/00000441-200502000-00005",
language = "English",
volume = "329",
pages = "78--85",
journal = "American Journal of the Medical Sciences",
issn = "0002-9629",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Incidence and management of "no-reflow" following percutaneous coronary interventions

AU - Kelly, R. V.

AU - Cohen, Mauricio G

AU - Stouffer, G. A.

PY - 2005/2/1

Y1 - 2005/2/1

N2 - No-reflow is a complex condition associated with inadequate myocardial perfusion of the coronary artery in the absence of epicardial obstruction. It can occur in several settings, including percutaneous coronary intervention, especially in complex thrombotic lesions of native arteries and vein grafts and in primary angioplasty. The causes of no-reflow are not completely understood, and current treatments consist of intracoronary vasodilators, antithrombotic therapies, and mechanical devices (including aspiration thrombectomy catheters and embolic protection devices).

AB - No-reflow is a complex condition associated with inadequate myocardial perfusion of the coronary artery in the absence of epicardial obstruction. It can occur in several settings, including percutaneous coronary intervention, especially in complex thrombotic lesions of native arteries and vein grafts and in primary angioplasty. The causes of no-reflow are not completely understood, and current treatments consist of intracoronary vasodilators, antithrombotic therapies, and mechanical devices (including aspiration thrombectomy catheters and embolic protection devices).

KW - Distal embolic protection

KW - Myocardial infarction

KW - Myocardial perfusion

KW - No-reflow

KW - Percutaneous coronary intervention

UR - http://www.scopus.com/inward/record.url?scp=13844255080&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13844255080&partnerID=8YFLogxK

U2 - 10.1097/00000441-200502000-00005

DO - 10.1097/00000441-200502000-00005

M3 - Article

C2 - 15711424

AN - SCOPUS:13844255080

VL - 329

SP - 78

EP - 85

JO - American Journal of the Medical Sciences

JF - American Journal of the Medical Sciences

SN - 0002-9629

IS - 2

ER -